Internal Medicine · 1997 · 32 citations · 8 references
MedicineImmunologyNephrologyAutoimmunityImmunopathologyRenal PathologyGlomerular DiseasesImmune-mediated Renal DiseaseRenal DiseaseRenal ImmunopathologySystemic Lupus ErythematosusSystemic SclerosisAnti-neutrophil Cytoplasmic AntibodiesAutoimmune GlomerulonephritisCorticosteroid Pulse TherapyRenal Biopsy DiagnosisRenal Biopsy FindingsRenal Failure ManagementScleroderma Renal CrisisScleroderma Treatment
A 46-year-old female patient who was diagnosed with systemic sclerosis (SSc) developed rapidly progressive renal failure without elevation of blood pressure or plasma renin concentration. Renal biopsy revealed necrotizing crescentic glomerulonephritis (pauci-immune type) and the myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA) titer was found to be elevated to 669 EU/ml. Methylprednisolone (MP) pulse therapy followed by prednisolone (PSL) and mizoribine (MZR) did not suppress the progression of renal failure. Therefore, we started double-filtration plasmapheresis (DFPP) which effectively removed MPO-ANCA and prevented renal failure despite the relatively low dose of immunosuppressive agents.
8
Hypertension and Renal Failure (Scleroderma Renal Crisis) in Progressive Systemic Sclerosis
Yehuda M. Traub, Alvin P. Shapiro, Gerald P. Rodnan et al. · Medicine · 1983 · 239 citations
Normotensive renal failure in systemic sclerosis
David J. Helfrich, Barbara F. Banner, Virginia Steen et al. · Arthritis & Rheumatism · 1989 · 219 citations
Medicine, Hematology, Nephrology +10